Mostrar el registro sencillo del ítem

dc.contributor.authorPaulino-Ramírez, Robert
dc.contributor.authorBáez, Amado Alejandro
dc.contributor.authorVallejo Degaudenzi, Alejandro
dc.contributor.authorTapía, Leandro
dc.date.accessioned2021-01-28T17:10:32Z
dc.date.available2021-01-28T17:10:32Z
dc.date.issued2020
dc.identifier.citationPaulino-Ramírez R, Báez A A, Vallejo Degaudenzi A, Tapía L. Seroprevalence of specific antibodies against SARS-CoV-2 from hotspot communities in the Dominican Republic. Am. J. Trop. Med. Hyg. [En línea]. 2020 [consultado día mes año]; ., 103(6): 2343-2346. Disponible en: doi:10.4269/ajtmh.20-0907.en_US
dc.identifier.urihttps://repositorio.unphu.edu.do/handle/123456789/3345
dc.description.abstractSeroprevalence surveys are of utmost importance to assess the proportion of a population that has developed antibodies against a newly introduced virus and could therefore potentially exhibit immunologic protection against subsequent infection. This study aims to understand the distribution of IgM and IgG antibodies in the Dominican Republic. We surveyed a total of 12,897 participants between April and June 2020 in 10 provinces of the Dominican Republic. Survey efforts in emerging hotspots yielded a positivity for all participants of anti–SARS-CoV-2 IgM of 3.8% and IgG of 5.4%, indicating that the pathogen was in circulation before the identification of those particular communities as hotspots. We found important age differences between participants who participated in the serological study where a higher mean age is associated IgM positivity and a lower age with IgG positivity. Our results highlight the need for strategies that involve community-based seroprevalence monitoring. These should preclude syndromic case identification. Also, the higher mean age of IgM-positive participants suggests that strategies based on syndromic surveillance could identify hotspots at later phases, based on the number of cases detected at the healthcare center, as such community-based seroprevalence monitoring may be an effective intervention for future outbreaksen_US
dc.language.isoenen_US
dc.publisherThe American Society of Tropical Medicine and Hygieneen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectInfecciones por Coronavirusen_US
dc.subjectAnticuerposen_US
dc.subjectCoronavirusen_US
dc.subjectRepública Dominicanaen_US
dc.titleSeroprevalence of specific antibodies against SARS-CoV-2 from hotspot communities in the Dominican Republic.en_US
dc.typeArticleen_US
dc.identifier.doidoi: 10.4269/ajtmh.20-0907


Ficheros en el ítem

Thumbnail
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivs 3.0 United States
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivs 3.0 United States